Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics. Established in 2003, MBH's mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies. Our Q system complies with AIFA/EU GMP requirements.

Products, services, technology

Process-related impurities/Contaminants - Product-related impurities - Protein characterisation - Comparability Study - Stability Study - Forced Degradation Study - Validation of Analytical Methods - Batch Certification - Established Analytical and DSP Platforms - Formulation Development - Aseptic Filling - Bioconjugation

Cooperation possibilities

Preclinical development - Analytical development - Cell line development (CLD) - GMP manufacturing (Mammalian and Microbial) for (non)-standard mAbs, and new molecular formats, e.g. bispecifics, ADCs, fusion proteins

Some insights
  • Via Tito Speri, 10, 00071 Area Produttiva, Metropolitan City of Rome Capital, Italy

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland

You may also be interested in